Simulations Plus
- Nasdaq: SLP
- S&P 600 component
GastroPlus
ADMET Predictor
MedChem Studio
DDDPlus
MedChem Designer
MembranePlus
Number of employees
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.
References
- Simulations Plus, Inc. - San Fernando Valley Business Journal - December 29, 2010
- Simulations Plus, Inc. - New York Times - Company Information
- Simulations Plus, Inc. - Datamonitor Company Profiles via Alacra Store - May 23, 2008
External links
- "U.S. FDA Licenses GastroPlus(TM)". Business Wire. 9 Jan 2007. Retrieved 2008-08-01.
- "U.S. EPA Licenses Simulations Plus' ADMET Predictor(TM) Software". Medical News Today. 19 Jun 2008. Retrieved 2008-08-01.